About this Journal Submit a Manuscript Table of Contents
ISRN Virology
Volume 2013 (2013), Article ID 834890, 11 pages
http://dx.doi.org/10.5402/2013/834890
Review Article

Human Herpesvirus 6 and Neuroinflammation

International Center for Infectiology Research (CIRI), INSERM U1111, CNRS UMR5308, University of Lyon 1, ENS-Lyon, 21 Avenue T. Garnier, 69365 Lyon, France

Received 21 January 2013; Accepted 13 February 2013

Academic Editors: B. Kim, M. Magnani, and L. Margolis

Copyright © 2013 Joséphine M. Reynaud and Branka Horvat. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Z. Salahuddin, D. V. Ablashi, P. D. Markham, et al., “Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders,” Science, vol. 234, no. 4776, pp. 596–601, 1986.
  2. G. Dominguez, T. R. Dambaugh, F. R. Stamey, S. Dewhurst, N. Inoue, and P. E. Pellett, “Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A,” Journal of Virology, vol. 73, no. 10, pp. 8040–8052, 1999. View at Scopus
  3. K. N. Ward, “The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent,” Journal of Clinical Virology, vol. 32, no. 3, pp. 183–193, 2005.
  4. F. Santoro, P. E. Kennedy, G. Locatelli, M. S. Malnati, E. A. Berger, and P. Lusso, “CD46 is a cellular receptor for human herpesvirus 6,” Cell, vol. 99, no. 7, pp. 817–827, 1999. View at Scopus
  5. M. Luppi, P. Barozzi, A. Maiorana, R. Marasca, and G. Torelli, “Human herpesvirus 6 infection in normal human brain tissue,” Journal of Infectious Diseases, vol. 169, no. 4, pp. 943–944, 1994. View at Scopus
  6. M. Luppi, P. Barozzi, A. Maiorana et al., “Human herpesvirus-6: a survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors,” Journal of Medical Virology, vol. 47, no. 1, pp. 105–111, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. P. B. Challoner, K. T. Smith, J. D. Parker, et al., “Plaque-associated expression of human herpesvirus 6 in multiple sclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 16, pp. 7440–7444, 1995.
  8. P. K. Chan, H. K. Ng, M. Hui, M. Ip, J. L. Cheung, and A. F. Cheng, “Presence of human herpesviruses 6, 7, and 8 DNA sequences in normal brain tissue,” Journal of Medical Virology, vol. 59, no. 4, pp. 491–495, 1999.
  9. P. K. Chan, H. K. Ng, M. Hui, and A. F. Cheng, “Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain,” Journal of Medical Virology, vol. 64, no. 1, pp. 42–46, 2001.
  10. L. Cuomo, P. Trivedi, M. R. Cardillo, et al., “Human herpesvirus 6 infection in neoplastic and normal brain tissue,” Journal of Medical Virology, vol. 63, no. 1, pp. 45–51, 2001.
  11. J. Chi, B. Gu, C. Zhang, et al., “Human herpesvirus 6 latent infection in patients with glioma,” The Journal of Infectious Diseases, vol. 206, no. 9, pp. 1394–1398, 2012.
  12. M. L. Opsahl and P. G. E. Kennedy, “Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter,” Brain, vol. 128, no. part 3, pp. 516–527, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C. B. Hall, M. T. Caserta, K. C. Schnabel et al., “Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A,” Clinical Infectious Diseases, vol. 26, no. 1, pp. 132–137, 1998. View at Scopus
  14. M. T. Caserta, C. B. Hall, K. Schnabel et al., “Neuroinvasion and persistence of human herpesvirus 6 in children,” Journal of Infectious Diseases, vol. 170, no. 6, pp. 1586–1589, 1994. View at Scopus
  15. E. Harberts, K. Yao, J. E. Wohler, et al., “Human herpesvirus-6 entry into the central nervous system through the olfactory pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 33, pp. 13734–13739, 2011.
  16. L. De Bolle, J. Van Loon, E. De Clercq, and L. Naesens, “Quantitative analysis of human herpesvirus 6 cell tropism,” Journal of Medical Virology, vol. 75, no. 1, pp. 76–85, 2005.
  17. J. L. Gardell, P. Dazin, J. Islar, T. Menge, C. P. Genain, and P. H. Lalive, “Apoptotic effects of Human Herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunity,” Journal of Clinical Virology, vol. 37, supplement 1, pp. S11–S16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Ahlqvist, J. Fotheringham, N. Akhyani, K. Yao, A. Fogdell-Hahn, and S. Jacobson, “Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes,” Journal of NeuroVirology, vol. 11, no. 4, pp. 384–394, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. V. Albright, E. Lavi, J. B. Black, S. Goldberg, M. J. O’Connor, and F. González-Scarano, “The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia,” Journal For Neurovirology, vol. 4, no. 5, pp. 486–494, 1998.
  20. J. Dietrich, B. M. Blumberg, M. Roshal et al., “Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties,” Journal of Neuroscience, vol. 24, no. 20, pp. 4875–4883, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Donati, N. Akhyani, A. Fogdell-Hahn et al., “Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections,” Neurology, vol. 61, no. 10, pp. 1405–1411, 2003. View at Scopus
  22. D. Donati, E. Martinelli, R. Cassiani-Ingoni et al., “Variant-specific tropism of human herpesvirus 6 in human astrocytes,” Journal of Virology, vol. 79, no. 15, pp. 9439–9448, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. He, M. McCarthy, Y. Zhou, B. Chandran, and C. Wood, “Infection of primary human fetal astrocytes by human herpesvirus 6,” Journal of Virology, vol. 70, no. 2, pp. 1296–1300, 1996.
  24. L. De Filippis, C. Foglieni, S. Silva, A. L. Vescovi, P. Lusso, and M. S. Malnati, “Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system,” Journal of Clinical Virology, vol. 37, supplement 1, pp. S27–32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Gu, G.-F. Zhang, L. Y. Li, et al., “Human herpesvirus 6A induces apoptosis of primary human fetal astrocytes via both caspase-dependent and -independent pathways,” Journal of Virology, vol. 8, p. 530, 2011.
  26. W. R. Drobyski, K. K. Knox, D. Majewski, and D. R. Carrigan, “Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient,” The New England Journal of Medicine, vol. 330, no. 19, pp. 1356–1360, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Øster, B. Bundgaard, and P. Höllsberg, “Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells,” Journal of Virology, vol. 79, no. 3, pp. 1961–1965.
  28. L. Li, B. Gu, F. Zhou, et al., “Human herpesvirus 6 suppresses T cell proliferation through induction of cell cycle arrest in infected cells in the G2/M phase,” Journal of Virology, vol. 85, no. 13, pp. 6774–6783, 2011.
  29. L. Flamand, J. Gosselin, I. Stefanescu, D. Ablashi, and J. Menezes, “Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation,” Blood, vol. 85, no. 5, pp. 1263–1271, 1995. View at Scopus
  30. Y. Inoue, M. Yasukawa, and S. Fujita, “Induction of T-cell apoptosis by human herpesvirus 6,” Journal of Virology, vol. 71, no. 5, pp. 3751–3759, 1997.
  31. M. Yasukawa, Y. Inoue, H. Ohminami, K. Terada, and S. Fujita, “Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection,” Journal of General Virology, vol. 79, part 1, pp. 143–147, 1998. View at Scopus
  32. L. Potenza, M. Luppi, P. Barozzi et al., “HHV-6A in syncytial giant-cell hepatitis,” The New England Journal of Medicine, vol. 359, no. 6, pp. 593–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. R. I. Fox, I. Saito, E. K. Chan, et al., “Viral genomes in lymphomas of patients with Sjögren’s syndrome,” Journal of Autoimmunity, vol. 2, no. 4, pp. 449–455, 1989.
  34. S. Ranger-Rogez, E. Vidal, F. Liozon, and F. Denis, “Primary Sjögren’s syndrome and antibodies to human herpesvirus type 6,” Clinical Infectious Diseases, vol. 19, pp. 1159–1160, 1994.
  35. G. R. F. Krueger, C. Sander, A. Hoffmann, A. Barth, B. Koch, and M. Braun, “Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases,” In Vivo, vol. 5, no. 3, pp. 217–225, 1991. View at Scopus
  36. R. Alvarez-Lafuente, B. Fernández-Gutiérrez, S. de Miguel, et al., “Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction,” Annals of the Rheumatic Diseases, vol. 64, no. 9, pp. 1357–1359, 2005.
  37. F. Broccolo, F. Drago, S. Paolino, et al., “Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases,” Journal of Clinical Virology, vol. 46, no. 1, pp. 43–46, 2009.
  38. E. Caselli, M. C. Zatelli, R. Rizzo, et al., “Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis,” PLoS Pathogens, vol. 8, no. 10, Article ID e1002951, 2012.
  39. A. Smith, F. Santoro, G. Di Lullo, L. Dagna, A. Verani, and P. Lusso, “Selective suppression of IL-12 production by human herpesvirus 6,” Blood, vol. 102, no. 8, pp. 2877–2884, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. A. P. Smith, C. Paolucci, G. Di Lullo, S. E. Burastero, F. Santoro, and P. Lusso, “Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6,” Journal of Virology, vol. 79, no. 5, pp. 2807–2813, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Arena, M. C. Liberto, D. Iannello, A. B. Capozza, and A. Focà, “Altered cytokine production after human herpes virus type 6 infection,” New Microbiologica, vol. 22, no. 4, pp. 293–300, 1999.
  42. L. Flamand, J. Gosselin, M. D'Addario et al., “Human herpesvirus 6 induces interleukin-1β and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures,” Journal of Virology, vol. 65, no. 9, pp. 5105–5110, 1991. View at Scopus
  43. H. Kikuta, A. Nakane, H. Lu, Y. Taguchi, T. Minagawa, and S. Matsumoto, “Interferon induction by human herpesvirus 6 in human mononuclear cells,” Journal of Infectious Diseases, vol. 162, no. 1, pp. 35–38, 1990. View at Scopus
  44. M. Mayne, C. Cheadle, S. S. Soldan et al., “Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms,” Journal of Virology, vol. 75, no. 23, pp. 11641–11650, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Meeuwsen, C. Persoon-Deen, M. Bsibsi et al., “Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A,” Journal of Neuroimmunology, vol. 164, no. 1-2, pp. 37–47, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Flamand, I. Stefanescu, and J. Menezes, “Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15,” Journal of Clinical Investigation, vol. 97, no. 6, pp. 1373–1381, 1996. View at Scopus
  47. A. Arena, M. C. Liberto, A. B. Capozza, and A. Focà, “Productive HHV-6 infection in differentiated U937 cells: role of TNFα in regulation of HHV-6,” New Microbiologica, vol. 20, no. 1, pp. 13–20, 1997. View at Scopus
  48. A. Arena, R. A. Merendino, L. Bonina, D. Iannello, G. Stassi, and P. Mastroeni, “Role of IL-15 on monocytic resistance to human herpesvirus 6 infection,” New Microbiologica, vol. 23, no. 2, pp. 105–112, 2000. View at Scopus
  49. I. Nordström and K. Eriksson, “HHV-6B induces IFN-lambda1 responses in cord plasmacytoid dendritic cells through TLR9,” PLoS ONE, vol. 7, no. 6, Article ID e38683, 2012.
  50. J. C. Grivel, Y. Ito, G. Fagà et al., “Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6,” Nature Medicine, vol. 7, no. 11, pp. 1232–1235, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. J.-C. Grivel, F. Santoro, S. Chen, et al., “Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo,” Journal of Virology, vol. 77, no. 15, pp. 8280–8289, 2003.
  52. A. Caruso, F. Favilli, A. Rotola et al., “Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures,” Journal of Medical Virology, vol. 70, no. 3, pp. 451–458, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Caruso, A. Rotola, M. Comar et al., “HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines,” Journal of Medical Virology, vol. 67, no. 4, pp. 528–533, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Inagi, R. Guntapong, M. Nakao, et al., “Human herpesvirus 6 induces IL-8 gene expression in human hepatoma cell line, Hep G2,” Journal of Medical Virology, vol. 49, no. 1, pp. 34–40, 1996.
  55. D. K. Braun, G. Dominguez, and P. E. Pellett, “Human herpesvirus 6,” Clinical Microbiology Reviews, vol. 10, no. 3, pp. 521–567, 1997.
  56. K. Yao, J. R. Crawford, A. L. Komaroff, D. V. Ablashi, and S. Jacobson, “Review part 2: human herpesvirus-6 in central nervous system diseases,” Journal of Medical Virology, vol. 82, no. 10, pp. 1669–1678, 2010.
  57. H. Agut, “Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections,” Journal of Clinical Virology, vol. 52, no. 3, pp. 164–171, 2011.
  58. D. M. Zerr, “Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation,” Journal of Clinical Virology, vol. 37, upplement 1, pp. S52–S56, 2006.
  59. K. Yamanishi, T. Okuno, K. Shiraki et al., “Identification of human herpesvirus-6 as a causal agent for exanthem subitum,” The Lancet, vol. 1, no. 8594, pp. 1065–1067, 1988. View at Scopus
  60. Y. Asano, T. Yoshikawa, S. Suga et al., “Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum),” Pediatrics, vol. 93, no. 1, pp. 104–108, 1994. View at Scopus
  61. C. B. Hall, C. E. Long, K. C. Schnabel et al., “Human herpesvirus-6 infection in children—a prospective study of complications and reactivation,” The New England Journal of Medicine, vol. 331, no. 7, pp. 432–438, 1994. View at Publisher · View at Google Scholar · View at Scopus
  62. S. R. Barone, M. H. Kaplan, and L. R. Krilov, “Human herpesvirus-6 infection in children with first febrile seizures,” Journal of Pediatrics, vol. 127, no. 1, pp. 95–97, 1995. View at Scopus
  63. Y. Asano, T. Yoshikawa, Y. Kajita et al., “Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection,” Archives of Disease in Childhood, vol. 67, no. 12, pp. 1484–1485, 1992. View at Scopus
  64. T. Olli-Lähdesmäki, L. Haataja, R. Parkkola, M. Waris, N. Bleyzac, and O. Ruuskanen, “High-dose ganciclovir in HHV-6 encephalitis of an immunocompetent child,” Pediatric Neurology, vol. 43, no. 1, pp. 53–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Yanagihara, K. Tanaka-Taya, Y. Itagaki et al., “Human herpesvirus 6 meningoencephalitis with sequelae,” Pediatric Infectious Disease Journal, vol. 14, no. 3, pp. 240–242, 1995. View at Scopus
  66. K. B. Howell, K. Tiedemann, G. Haeusler, et al., “Symptomatic generalized epilepsy after HHV6 posttransplant acute limbic encephalitis in children,” Epilepsia, vol. 53, no. 7, pp. e122–e126, 2012.
  67. T. Yoshikawa, M. Ohashi, F. Miyake et al., “Exanthem subitum-associated encephalitis: nationwide survey in Japan,” Pediatric Neurology, vol. 41, no. 5, pp. 353–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Matsumoto, D. Hatanaka, Y. Ogura, A. Chida, Y. Nakamura, and S. Nonoyama, “Severe human herpesvirus 6-associated encephalopathy in three children: analysis of cytokine profiles and the carnitine palmitoyltransferase 2 gene,” The Pediatric Infectious Disease Journal, vol. 30, no. 11, pp. 999–1001, 2011.
  69. M. Patnaik and J. B. Peter, “Intrathecal synthesis of antibodies to human herpesvirus 6 early antigen in patients with meningitis/encephalitis,” Clinical Infectious Diseases, vol. 21, no. 3, pp. 715–716, 1995.
  70. T. Birnbaum, C. S. Padovan, B. Sporer et al., “Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompetent woman treated with ganciclovir,” Clinical Infectious Diseases, vol. 40, no. 6, pp. 887–889, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Isaacson, C. A. Glaser, B. Forghani et al., “Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis,” Clinical Infectious Diseases, vol. 40, no. 6, pp. 890–893, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. J. A. McCullers, F. D. Lakeman, and R. J. Whitley, “Human herpesvirus 6 is associated with focal encephalitis,” Clinical Infectious Diseases, vol. 21, no. 3, pp. 571–576, 1995.
  73. K. Yao, S. Honarmand, A. Espinosa, N. Akhyani, C. Glaser, and S. Jacobson, “Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis,” Annals of Neurology, vol. 65, no. 3, pp. 257–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. N. P. Tavakoli, S. Nattanmai, R. Hull et al., “Detection and typing of human herpesvirus 6 by molecular methods in specimens from patients diagnosed with encephalitis or meningitis,” Journal of Clinical Microbiology, vol. 45, no. 12, pp. 3972–3978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. T. Yoshikawa, Y. Asano, M. Ihira et al., “Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors,” Journal of Infectious Diseases, vol. 185, no. 7, pp. 847–853, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Ogata, “Human herpesvirus 6 in hematological malignancies,” Journal of Clinical and Experimental Hematopathology, vol. 49, no. 2, pp. 57–67, 2009.
  77. J. Fotheringham, N. Akhyani, A. Vortmeyer et al., “Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid,” Journal of Infectious Diseases, vol. 195, no. 3, pp. 450–454, 2007. View at Scopus
  78. F. Forest, S. Duband, S. Pillet, et al., “Lethal human herpesvirus-6 encephalitis after cord blood transplant,” Transplant Infectious Disease, vol. 13, no. 6, pp. 646–649, 2011.
  79. P. Ljungman, F. Z. Wang, D. A. Clark et al., “High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients,” British Journal of Haematology, vol. 111, no. 3, pp. 774–781, 2000. View at Publisher · View at Google Scholar · View at Scopus
  80. D. M. Zerr, T. A. Gooley, L. Yeung et al., “Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients,” Clinical Infectious Diseases, vol. 33, no. 6, pp. 763–771, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Ogata, H. Kikuchi, T. Satou et al., “Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance,” Journal of Infectious Diseases, vol. 193, no. 1, pp. 68–79, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. F. Wilborn, C. A. Schmidt, V. Brinkmann, K. Jendroska, H. Oettle, and W. Siegert, “A potential role for human herpesvirus type 6 in nervous system disease,” Journal of Neuroimmunology, vol. 49, no. 1-2, pp. 213–214, 1994. View at Publisher · View at Google Scholar · View at Scopus
  83. S. S. Soldan, R. Berti, N. Salem et al., “Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA,” Nature Medicine, vol. 3, no. 12, pp. 1394–1397, 1997. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Chapenko, A. Millers, Z. Nora, I. Logina, R. Kukaine, and M. Murovska, “Correlation between HHV-6 reactivation and multiple sclerosis disease activity,” Journal of Medical Virology, vol. 69, no. 1, pp. 111–117, 2003.
  85. M. Garcia-Montojo, A. Martinez, V. De Las Heras, et al., “Herpesvirus active replication in multiple sclerosis: a genetic control?” Journal of the Neurological Sciences, vol. 311, no. 1-2, pp. 98–102, 2011.
  86. D. V. Ablashi, W. Lapps, M. Kaplan, J. E. Whitman, J. R. Richert, and G. R. Pearson, “Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report,” Multiple Sclerosis, vol. 4, no. 6, pp. 490–496, 1998. View at Scopus
  87. J. E. Friedman, M. J. Lyons, G. Cu et al., “The association of the human herpesvirus-6 and MS,” Multiple Sclerosis, vol. 5, no. 5, pp. 355–362, 1999. View at Scopus
  88. S. S. Soldan, T. P. Leist, K. N. Juhng, H. F. McFarland, and S. Jacobson, “Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients,” Annals of Neurology, vol. 47, no. 3, pp. 306–313, 2000.
  89. V. J. Sanders, S. Felisan, A. Waddell, and W. W. Tourtellotte, “Detection of Herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction,” Journal of NeuroVirology, vol. 2, no. 4, pp. 249–258, 1996. View at Scopus
  90. A. D. Goodman, D. J. Mock, J. M. Powers, J. V. Baker, and B. M. Blumberg, “Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions,” The Journal of Infectious Diseases, vol. 187, no. 9, pp. 1365–1376, 2003.
  91. R. Berti, M. B. Brennan, S. S. Soldan et al., “Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression,” Journal of NeuroVirology, vol. 8, no. 3, pp. 250–256, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Alvarez-Lafuente, V. De las Heras, M. Bartolomé, J. J. Picazo, and R. Arroyo, “Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection,” Archives of Neurology, vol. 61, no. 10, pp. 1523–1527, 2004.
  93. S. Simpson Jr., B. Taylor, D. E. Dwyer, et al., “Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis,” Multiple Sclerosis, vol. 18, no. 6, pp. 799–806, 2012.
  94. N. Akhyani, R. Berti, M. B. Brennan et al., “Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis,” Journal of Infectious Diseases, vol. 182, no. 5, pp. 1321–1325, 2000. View at Publisher · View at Google Scholar · View at Scopus
  95. J. Ongrádi, C. Rajda, C. L. Maródi, A. Csiszár, and L. Vecsei, “A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients,” Journal For Neurovirology, vol. 5, no. 5, pp. 529–532, 1999.
  96. A. M. Fillet, P. Lozeron, H. Agut et al., “HHV-6 and multiple sclerosis,” Nature Medicine, vol. 4, no. 5, pp. 537–538, 1998. View at Scopus
  97. A. R. Coates and J. Bell, “HHV-6 and multiple sclerosis,” Nature Medicine, vol. 4, no. 5, pp. 537–538, 1998.
  98. K. I. Voumvourakis, D. K. Kitsos, S. Tsiodras, G. Petrikkos, and E. Stamboulis, “Human herpesvirus 6 infection as a trigger of multiple sclerosis,” Mayo Clinic Proceedings, vol. 85, no. 11, pp. 1023–1030, 2010.
  99. M. Cirone, L. Cuomo, C. Zompetta et al., “Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens,” Journal of Medical Virology, vol. 68, no. 2, pp. 268–272, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. M. V. Tejada-Simon, Y. C. Q. Zang, J. Hong, V. M. Rivera, and J. Z. Zhang, “Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis,” Annals of Neurology, vol. 53, no. 2, pp. 189–197, 2003.
  101. W. Cheng, Y. Ma, F. Gong, et al., “Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS,” Frontiers in Bioscience, vol. 17, pp. 1648–1658, 2012.
  102. C. S. Jack, N. Arbour, J. Manusow et al., “TLR signaling tailors innate immune responses in human microglia and astrocytes,” Journal of Immunology, vol. 175, no. 7, pp. 4320–4330, 2005. View at Scopus
  103. M. Bsibsi, R. Ravid, D. Gveric, and J. M. Van Noort, “Broad expression of Toll-like receptors in the human central nervous system,” Journal of Neuropathology and Experimental Neurology, vol. 61, no. 11, pp. 1013–1021, 2002. View at Scopus
  104. M. Lafon, F. Megret, M. Lafage, and C. Prehaud, “The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA,” Journal of Molecular Neuroscience, vol. 29, no. 3, pp. 185–194, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. H. Kong, Q. Baerbig, L. Duncan, N. Shepel, and M. Mayne, “Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death,” Journal of NeuroVirology, vol. 9, no. 5, pp. 539–550, 2003. View at Scopus
  106. Y. Isegawa, Z. Ping, K. Nakano, N. Sugimoto, and K. Yamanishi, “Human herpesvirus 6 open reading frame U12 encodes a functional β- chemokine receptor,” Journal of Virology, vol. 72, no. 7, pp. 6104–6112, 1998. View at Scopus
  107. R. S. B. Milne, C. Mattick, L. Nicholson, P. Devaraj, A. Alcami, and U. A. Gompels, “RANTES binding and down-regulation by a novel human herpesvirus-6 β chemokine receptor,” Journal of Immunology, vol. 164, no. 5, pp. 2396–2404, 2000. View at Scopus
  108. P. Zou, Y. Isegawa, K. Nakano, M. Haque, Y. Horiguchi, and K. Yamanishi, “Human herpesvirus 6 open reading frame U83 encodes a functional chemokine,” Journal of Virology, vol. 73, no. 7, pp. 5926–5933, 1999. View at Scopus
  109. H. R. Lüttichau, I. Clark-Lewis, P. Ø. Jensen, C. Moser, J. Gerstoft, and T. W. Schwartz, “A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6,” The Journal of Biological Chemistry, vol. 278, no. 13, pp. 10928–10933, 2003.
  110. D. R. Dewin, J. Catusse, and U. A. Gompels, “Identification and characterization of U83A viral chemokine, a broad and potent β-chemokine agonist for human CCRs with unique selectivity and inhibition by spliced isoform,” Journal of Immunology, vol. 176, no. 1, pp. 544–556, 2006. View at Scopus
  111. C. A. Wu and J. D. Shanley, “Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6,” Journal of General Virology, vol. 79, part 5, pp. 1247–1256, 1998.
  112. I. Lautenschlager, M. Härmä, K. Höckerstedt, K. Linnavuori, R. Loginov, and E. Taskinen, “Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts,” Journal of Hepatology, vol. 37, no. 5, pp. 648–654, 2002.
  113. J. C. Marie, A. L. Astier, P. Rivailler, C. Rabourdin-Combe, T. F. Wild, and B. Horvat, “Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell-induced inflammation,” Nature Immunology, vol. 3, no. 7, pp. 659–666, 2002. View at Publisher · View at Google Scholar · View at Scopus
  114. C. Kemper, A. C. Chan, J. M. Green, K. A. Brett, K. M. Murphy, and J. P. Atkinson, “Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype,” Nature, vol. 421, no. 6921, pp. 388–392, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. R. Alvarez-Lafuente, M. Garcia-Montojo, V. De Las Heras, M. I. Dominguez-Mozo, M. Bartolome, and R. Arroyo, “CD46 expression and HHV-6 infection in patients with multiple sclerosis,” Acta Neurologica Scandinavica, vol. 120, no. 4, pp. 246–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. A. L. Astier, G. Meiffren, S. Freeman, and D. A. Hafler, “Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis,” Journal of Clinical Investigation, vol. 116, no. 12, pp. 3252–3257, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. A. Vaknin-Dembinsky, G. Murugaiyan, D. A. Hafler, A. L. Astier, and H. L. Weiner, “Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis,” Journal of Neuroimmunology, vol. 195, no. 1-2, pp. 140–145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. K. Yao, J. Graham, Y. Akahata, U. Oh, and S. Jacobson, “Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding,” Journal of Hepatology, vol. 5, no. 3, pp. 469–478, 2010.
  119. H. Perron, C. Bernard, J. B. Bertrand et al., “Endogenous retroviral genes, herpesviruses and gender in multiple sclerosis,” Journal of the Neurological Sciences, vol. 286, no. 1-2, pp. 65–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. H. Perron, J. A. Garson, F. Bedin et al., “Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 14, pp. 7583–7588, 1997. View at Publisher · View at Google Scholar · View at Scopus
  121. J. M. Antony, G. Van Marle, W. Opii et al., “Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination,” Nature Neuroscience, vol. 7, no. 10, pp. 1088–1095, 2004. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Rolland, E. Jouvin-Marche, C. Viret, M. Faure, H. Perron, and P. N. Marche, “The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses,” Journal of Immunology, vol. 176, no. 12, pp. 7636–7644, 2006. View at Scopus
  123. T. Brudek, P. Lühdorf, T. Christensen, H. J. Hansen, and A. Møller-Larsen, “Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV,” Journal of Neuroimmunology, vol. 187, no. 1-2, pp. 147–155, 2007.
  124. A. K. Tai, J. Luka, D. Ablashi, and B. T. Huber, “HHV-6A infection induces expression of HERV-K18-encoded superantigen,” Journal of Clinical Virology, vol. 46, no. 1, pp. 47–48, 2009.
  125. V. L. Turcanova, B. Bundgaard, and P. Höllsberg, “Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen,” Journal of Clinical Virology, vol. 46, no. 1, pp. 15–19, 2009.
  126. C. Li, J. M. Goodrich, and X. Yang, “Interferon-gamma (IFN-γ) regulates production of IL-10 and IL-12 in human herpesvirus-6 (HHV-6)-infected monocyte/macrophage lineage,” Clinical and Experimental Immunology, vol. 109, no. 3, pp. 421–425, 1997. View at Scopus
  127. T. Yoshikawa, Y. Asano, S. Akimoto et al., “Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis,” Journal of Medical Virology, vol. 66, no. 4, pp. 497–505, 2002. View at Publisher · View at Google Scholar · View at Scopus